Literature DB >> 1840271

The putative oncogene PRAD1 encodes a novel cyclin.

A Arnold1, T Motokura, T Bloom, H Kronenberg, J Ruderman, H Jüppner, H G Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1840271     DOI： 10.1101/sqb.1991.056.01.013

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  4 in total

Review 1.  D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.

Authors:  Qian Zhang; Kazuhito Sakamoto; Kay-Uwe Wagner
Journal:  Mol Cell Endocrinol       Date:  2013-04-04       Impact factor: 4.102

2.  Growth factor-induced delayed early response genes.

Authors:  A Lanahan; J B Williams; L K Sanders; D Nathans
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

Review 3.  Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology.

Authors:  Gabriele Di Sante; Jessica Pagé; Xuanmao Jiao; Omar Nawab; Massimo Cristofanilli; Emmanuel Skordalakes; Richard G Pestell
Journal:  Expert Rev Anticancer Ther       Date:  2019-06-20       Impact factor: 4.512

4.  The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression.

Authors:  Yong-Jin Yang; Jeung-Whan Han; Hong-Duk Youn; Eun-Jung Cho
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.